TPHF: Treatment of Proximal Humeral Fractures

Sponsor
Tampere University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT01246167
Collaborator
Kuopio University Hospital (Other), Jyväskylä Central Hospital (Other), Karolinska University Hospital (Other), Tampere University (Other), Academy of Finland (Other), Uppsala University Hospital (Other), Aarhus University Hospital (Other), Regionaalhaigla, Tallinn (Other), Tartu University Hospital (Other)
250
6
3
106
41.7
0.4

Study Details

Study Description

Brief Summary

This trial is designed to compare head-to-head conservative with operative treatment in 2 stratum. Stratum 1: In 2 part fractures the comparison is between conservative treatment and operative treatment with plate fixation with Philos. Stratum 2: In multi-fragmented fractures (MFF) meaning 3 and 4 part fractures, the comparison is between conservative treatment, operative treatment with Philos plate and operative treatment with Epoca prosthesis. Subgroup analysis will be performed in an effort to obtain limit values for specific treatment of different age and fracture groups. A cost-effectiveness analysis and comparison between different treatment modalities will be carried out. The primary outcome measure will be the DASH score and the secondary outcome measure the EQ-5D value. Recruitment period is 3 years and follow-up 2 years.

Condition or Disease Intervention/Treatment Phase
  • Device: Philos
  • Device: Epoca
  • Other: Control group
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
250 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
An International, Prospective, Randomized, Multicenter, Controlled Head-to-Head Comparison of Conservative, Plate Fixation and Prosthesis in Treatment of Displaced 2, 3, and 4 Part Fractures of Proximal Humerus of 60 Years and Older Patients
Study Start Date :
Jan 1, 2011
Actual Primary Completion Date :
Nov 1, 2019
Actual Study Completion Date :
Nov 1, 2019

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Conservative

Active physiotherapy and self-training

Other: Control group
Conservative control group

Active Comparator: Philos locking plate

After operative treatment active physiotherapy and self-training

Device: Philos
Conservative treatment versus Philos locking plate in 2 part fracture group. Conservative treatment versus Philos locking plating versus Epoca prosthesis in MFF group.

Active Comparator: Epoca prosthesis

After operative treatment active physiotherapy and self-training

Device: Epoca
Conservative treatment versus Philos locking plate versus Epoca fracture prosthesis in MFF group

Outcome Measures

Primary Outcome Measures

  1. DASH [6 months]

    to measure physical function and symptoms of the fractured shoulder

  2. DASH [1 year]

    to measure physical function and symptoms of the fractured shoulder

  3. DASH [2 year]

    to measure physical function and symptoms of the fractured shoulder

Secondary Outcome Measures

  1. EQ-5D [6 month]

    Individual's general health related quality of life is measured with EQ-5D

  2. EQ-5D [1 year]

    Individual's general health related quality of life is measured with EQ-5D

  3. EQ-5D [2 year]

    Individual's general health related quality of life is measured with EQ-5D

Eligibility Criteria

Criteria

Ages Eligible for Study:
60 Years to 100 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Low energy proximal humeral displaced (more than 1 cm or 45 degrees) 2 part fracture where fracture line emerges through the surgical (or anatomical) neck

  • Low energy proximal humeral displaced (more than 1 cm or 45 degrees) 3 or 4 part fracture

Exclusion Criteria:
  • Refuse to participate the study

  • Less than 60 years old

  • Non-independent

  • Dementia and/or institutionalized

  • Does no understand written and spoken guidance in either Finnish or Swedish

  • Pathological fracture or previous fracture in the same proximal humerus

  • Serious intoxicant dependent, eg. In first aid breathalyzer shows more than 2‰

  • Other operational injury in the same upper limb

  • Major nerve injury (eg. Complete radialis- or delta palsy)

  • Open fracture

  • Multi-trauma or -fractured patient

  • Fracture dislocation or head splitting fracture

  • Undisplaced fracture

  • Isolated tuberculum fracture

  • Fracture has no precondition to ossify by conservative treatment (no bony contact between fracture parts or the humeral shaft is in contact with the articular surface)

  • Treating surgeon considers patient unsuitable to attend the study on medical basis

  • Cuff-arthropathy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Aarhus University Hospital Aarhus Denmark
2 Regionaalhaigla, PERH Tallinn Estonia
3 Jyväskylä Central Hospital Jyväskylä Keski-Suomi Finland 40620
4 Tampere University Hospital Tampere Pirkanmaa Finland 33521
5 Karolinska University Hospital Stockholm Sweden
6 Uppsala University Hospital Uppsala Sweden

Sponsors and Collaborators

  • Tampere University Hospital
  • Kuopio University Hospital
  • Jyväskylä Central Hospital
  • Karolinska University Hospital
  • Tampere University
  • Academy of Finland
  • Uppsala University Hospital
  • Aarhus University Hospital
  • Regionaalhaigla, Tallinn
  • Tartu University Hospital

Investigators

  • Principal Investigator: Minna Laitinen, Docent, Tampere University Hospital
  • Study Director: Antti Launonen, MD, Tampere University Hospital
  • Study Chair: Pekka Rissanen, Professor, Tampere University
  • Study Chair: Johanna Ojanperä, MD, Kuopio University Hospital
  • Study Chair: Vesa Lepola, MD, PhD, Tampere University Hospital
  • Study Chair: Timo Viljakka, MD, Tampere University Hospital
  • Study Chair: Ville M Mattila, Professor, Tampere University Hospital
  • Study Chair: Juha Paloneva, MD PhD, Jyväskylä Central Hospital
  • Study Chair: Hans Berg, Docent, Karolinska University Hospital
  • Study Chair: Karl-Åke Jansson, Docent, Karolinska University Hospital
  • Study Chair: Kjeld Soballe, Professor, Aarhus University Hospital
  • Study Chair: Kaj Dossing, MD, Central Jutland Regional Hospital
  • Study Chair: Helle Ostergaard, Msc, Central Jutland Regional Hospital
  • Study Chair: Inger Mechlenburg, PhD, University of Aarhus

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Antti Launonen, MD, Tampere University Hospital
ClinicalTrials.gov Identifier:
NCT01246167
Other Study ID Numbers:
  • R10127
First Posted:
Nov 23, 2010
Last Update Posted:
Mar 10, 2020
Last Verified:
Mar 1, 2020
Keywords provided by Antti Launonen, MD, Tampere University Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 10, 2020